Repository logo
 
Publication

Therapeutic drug monitoring education: The current state

2025-08-26Research article Open access
Simple item page
dc.contributor.authorPetrova, Guenka
dc.contributor.authorBlagova, Stiliyana
dc.contributor.authorTachkov, Konstantin
dc.contributor.authorSantos, Marlene
dc.contributor.authorBluett, James
dc.contributor.authorRumano, Merita
dc.contributor.authorKkolou, Elena
dc.contributor.authorDrakalska, Elena
dc.contributor.authorArev, Marija
dc.contributor.authorBarsbay, Mehtap Cakmak
dc.contributor.authorMulleman, Denis
dc.contributor.authorSantos, Marlene
dc.date.accessioned2025-10-17T09:50:48Z
dc.date.available2025-10-17T09:50:48Z
dc.date.issued2025-08-26
dc.description.abstractTo evaluate available information on therapeutic drug monitoring (TDM) education programmes and their implementation across different countries. The study was performed in two phases. First, a scoping review of scientific literature on available education programmes was performed. Afterwards, a questionnaire was distributed among a worldwide network of professionals engaged in the practice of TDM. Eight scientific articles discussing TDM educational programmes were found. They described in depth an educational programme on TDM, which was primarily offered as postgraduate education programme for hospital staff. We received a total 23 responses (30% response rate); of these, 68% were from academia. For 70% of respondents, TDM is part of the educational programme of healthcare professionals, and for 56% it is offered at both undergraduate and postgraduate level, aimed mainly at physicians (39%) and pharmacists (65%). TDM is mainly performed in infectious diseases (n = 15), neurology (n = 14) and psychiatry (n = 12), as well as for antibiotics (83%), monoclonal antibodies (53%), and oncology and psychotropics (48%). Funding for TDM is derived mostly from public health insurance (48%), hospital (44%), patients (39%). In some cases, patients might co-pay to hospital or to health insurance fund. Education on TDM is scattered across different subjects, disciplines and degrees. It is oriented essentially towards physicians and pharmacists, and its funding is mainly public. General guidelines are lacking. In light of this, it is necessary to consider developing a comprehensive educational programme on TDM, oriented towards relevant drugs and diseases, and encompassing appropriate analytical and pharmacological methods.por
dc.identifier.citationPetrova, G., Blagova, S., Tachkov, K., Santos, M., Bluett, J., Rumano, M., Kkolou, E., Drakalska, E., Arev, M., Barsbay, M. C., & Mulleman, D. (2025). Therapeutic drug monitoring education: The current state. British Journal of Clinical Pharmacology, n/a(n/a). https://doi.org/10.1002/bcp.70252
dc.identifier.doi10.1002/bcp.70252
dc.identifier.eissn1365-2125
dc.identifier.issn0306-5251
dc.identifier.urihttp://hdl.handle.net/10400.22/30625
dc.language.isoeng
dc.peerreviewedyes
dc.publisherThe British Pharmacological Society
dc.relation.hasversionhttps://bpspubs.onlinelibrary.wiley.com/doi/10.1002/bcp.70252
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectEducation programmes
dc.subjectHealthcare professionals
dc.subjectTherapeutic drug monitoring
dc.titleTherapeutic drug monitoring education: The current statepor
dc.typeresearch article
dspace.entity.typePublication
oaire.citation.titleBritish Journal of Clinical Pharmacology
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
person.familyNameSantos
person.givenNameMarlene
person.identifier1508370
person.identifier.ciencia-id8311-B967-31C4
person.identifier.orcid0000-0001-5020-5942
person.identifier.scopus-author-id57110502000
relation.isAuthorOfPublication8ce9ee39-a4c6-46ae-99e2-49397b550f1b
relation.isAuthorOfPublication.latestForDiscovery8ce9ee39-a4c6-46ae-99e2-49397b550f1b

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ART_Marlene Santos.pdf
Size:
1.5 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.03 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

ESS - CISA - Artigos
ESS - FAR - Artigos